The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer (Q34656089)

3 August 2017

title

The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer (English)

1 reference

3 August 2017

1 reference

10

Christine Spitzweg

1 reference

3 August 2017

1

Michael J Willhauck

1 reference

3 August 2017

Bibi-Rana Sharif Samani

2

object named as

Bibi-Rana Sharif Samani

1 reference

Reingard Senekowitsch-Schmidtke

3 August 2017

4

object named as

Reingard Senekowitsch-Schmidtke

1 reference

3 August 2017

Ingo Wolf

3

1 reference

3 August 2017

Hans-Jürgen Stark

5

1 reference

3 August 2017

Geerd J Meyer

6

1 reference

3 August 2017

Wolfram H Knapp

7

1 reference

3 August 2017

Burkhard Göke

8

1 reference

3 August 2017

John C Morris

9

1 reference

3 August 2017

publication date

11 April 2008

1 reference

3 August 2017

number of pages

10

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

3 August 2017

volume

35

1 reference

3 August 2017

issue

7

1 reference

3 August 2017

page(s)

1272-1281

1 reference

External targets for the production of 211At--review and status of the target development at the Hannover cyclotron

3 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-008-0775-4

Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3).

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-008-0775-4

Cloning of a functional promoter of the human sodium/iodide-symporter gene

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-008-0775-4

Sodium-iodide symporter (NIS)-mediated accumulation of [(211)At]astatide in NIS-transfected human cancer cells

21 January 2018

1 reference

12 December 2020

Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I- symporter gene

1 reference

12 December 2020

In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.

1 reference

12 December 2020

Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells.

1 reference

12 December 2020

Dexamethasone enhances the cytotoxic effect of radioiodine therapy in prostate cancer cells expressing the sodium iodide symporter

1 reference

12 December 2020

Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells

1 reference

12 December 2020

Induction of DNA double-strand breaks by ionizing radiation of different quality and their relevance for cell inactivation

1 reference

12 December 2020

Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose

1 reference

12 December 2020

A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression

1 reference

12 December 2020

Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter

1 reference

12 December 2020

In vitro cytotoxicity of (211)at-astatide and (131)I-iodide to glioma tumor cells expressing the sodium/iodide symporter

1 reference

12 December 2020

Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands

1 reference

12 December 2020

Radioisotope concentrator gene therapy using the sodium/iodide symporter gene.

1 reference

12 December 2020

1 reference

12 December 2020

The Na+/I- symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid

1 reference

12 December 2020

Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line

1 reference

12 December 2020

Genetically targeted radiotherapy for multiple myeloma

1 reference

12 December 2020

Iodide transport in a continuous line of cultured cells from rat thyroid

1 reference

12 December 2020

Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter

1 reference

12 December 2020

Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer

1 reference

12 December 2020

Novel degradable oligoethylenimine acrylate ester-based pseudodendrimers for in vitro and in vivo gene transfer

1 reference

12 December 2020

Prostate cancer: therapeutic, diagnostic, and basic studies

1 reference

12 December 2020

Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice.

1 reference

12 December 2020

Application of 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression

1 reference

12 December 2020

The mammary gland iodide transporter is expressed during lactation and in breast cancer

1 reference

12 December 2020

A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancer.

1 reference

12 December 2020

Gene therapy for prostate cancer: current status and future prospects

1 reference

12 December 2020

Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.

1 reference

12 December 2020

Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy

1 reference

12 December 2020

Anion selectivity by the sodium iodide symporter.

1 reference

12 December 2020

The sodium iodide symporter: its pathophysiological and therapeutic implications

1 reference

12 December 2020

The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance

1 reference

12 December 2020

In vivo sodium iodide symporter gene therapy of prostate cancer

1 reference

12 December 2020

Effective cancer therapy with the alpha-particle emitter [211At]astatine in a mouse model of genetically modified sodium/iodide symporter-expressing tumors

1 reference

12 December 2020

Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression

1 reference

12 December 2020

211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.

1 reference

12 December 2020

Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors.

1 reference

12 December 2020

Radiotoxicity of systematically administered [211At]astatide in B6C3F1 and BALB/c (nu/nu) mice: a long-term survival study with histologic analysis

1 reference

12 December 2020

Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer

1 reference

12 December 2020

Current status of therapy of solid tumors: brain tumor therapy.

1 reference

12 December 2020

Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two-and three-dimensional models.

1 reference

12 December 2020

Cloning and characterization of the thyroid iodide transporter

1 reference

12 December 2020

10.1007/S00259-008-0775-4

Identifiers

DOI

1 reference

3 August 2017

1 reference